Vaccine Therapy in Treating Patients With Advanced Refractory or Recurrent Non-Small Cell Lung Cancer - Contacts and Locations

Vaccine Therapy in Treating Patients With Advanced Refractory or Recurrent Non-Small Cell Lung Cancer

This study is currently recruiting participants.

Study NCT00075790. Last updated on October 24, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00075790

Locations


United States, Georgia
	Medical College of Georgia Cancer Center	Recruiting
	Augusta, Georgia, United States, 30912
	Contact: Stacy Haun, RN, BSN 706-721-3453

United States, Maryland
	Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office	Recruiting
	Bethesda, Maryland, United States, 20892-1182
	Contact: Contact Person 888-NCI-1937

Sponsors and Collaborators

NCI - Center for Cancer Research-Medical Oncology

National Cancer Institute (NCI)

Investigators


Study Chair:	John C. Morris, MD	NCI - Metabolism Branch;MET

Investigator:	Charles Joseph Link, MD	NewLink Genetics Corporation